Unbiased Analysis of Today's Healthcare Issues
Today I participated in a fantastic panel presentation at the 2018 Academy of Managed Care & Specialty Pharmacy Conference in Boston. Moderated by Jonathan Collar of Cigna-Health Spring, the session discussed “New Tools for Measuring Treatment Value in Rheumatoid Arthritis“. My co-presenters were Jeroen Jansen from the Innovation and Value Initiative and Dr. Jeff Curtis, a…
As reported in a Academy of Managed Care & Specialty Pharmacy newsletter, titled “Mathematical Model Aims to Improve Cost-Effectiveness of Rheumatology Treatment“, the Innovation and Value Initiative’s is highlighted from the American College of Rheumatology conference. Here is an excerpt: Biological therapies for moderate to severe rheumatoid arthritis have significantly improved treatment and prognosis. However,…
That is the question that the Outcome Measures in Rheumatology (OMERACT) Working Group attempted to answer. Specifically, the working group aimed to determine the core set of outcome domains for measuring the effectiveness of shared decision-making (SDM) interventions within clinical trials used to treat rheumatic diseases. These diseases included osteoarthritis (OA), rheumatoid arthritis (RA), and psoriatic…
This is the title of my latest article in JMCP co-authored with Arijit Ganguli, Yuri Sanchez Gonzalez, Jin Joo Shim, and Seth A. Seabury. The paper’s abstract is below. BACKGROUND: There is considerable push to improve value in health care by simultaneously increasing quality while lowering or containing costs. However, for diseases that are best…